A REVIEW ON BIOCHEMICAL AND THERAPEUTIC ASPECTS OF GLUTAMINASEHTML Full Text
A REVIEW ON BIOCHEMICAL AND THERAPEUTIC ASPECTS OF GLUTAMINASE
Rahamat Unissa *, M. Sudhakar, A. Sunil Kumar Reddy and K. Naga Sravanthi
Malla Reddy College of Pharmacy, Maisammaguda, Dhulapally, Secunderabad - 500014, Hyderabad. India.
ABSTRACT: One of the prime candidates in the treatment of debilitating human cancers includes a family of enzymes referred to as L- glutaminases. The antitumor activity of these enzymes found effective in countering Acute Lymphoblastic Leukemia (ALL a commonly diagnosed pediatric cancer.). Further it is found to inhibit four human tumour cell lines namely Hep-G2 [Human hepatocellular carcinoma cell line], MCF-7 [Breast cancer cell line], HCT-116 [Colon cell line] and A549 [Human lung Carcinoma]. Apart from therapeutic use, it is having a number of other applications like in food industry, analysis and in production of fine chemicals. This review, hence, mainly focuses on the biochemical aspects of L-Glutaminase production, aiming to comprehend the physiochemical characteristics, application of L-Glutaminase and its properties. Processes central to these biochemical aspects, including submerged fermentation and Solid state fermentation of L- glutaminase producing organisms are also discussed.
L-Glutaminase, Submerged fermentation, Solid state fermentation, Acute lymphoblastic leukemia, Human hepatocellular carcinoma cell line, Breast cancer cell line
INTRODUCTION: L-Glutaminase (L-glutamine amidohydrolase E.C 126.96.36.199) is the enzyme that catalyzes the deamidation of L-glutamine to L-glutamic acid and ammonia 1, 2. This is an essential enzyme for the synthesis of various nitrogenous metabolic intermediates 3. L-Glutaminase has received significant attention since it was reported extensively as antileukemic agent 4-6. Unlike normal cells, leukemic cell do not demonstrate the L-glutamine synthetase, thus it is dependent on the exogenous supply of L-glutamine for their growth and survival 7.
Tumour cells have an absolute requirement for glutamine as a growth substrate. Glutamine is required as a precursor for both DNA synthesis and protein synthesis and may also be used as a respiratory substrate.
In experiments where glutamine metabolism in tumour cells has been specifically compared with that in non-transformed cells of the same origin, glutamine metabolism in the tumour cells has been found to be considerably faster. This is true for human hepatocytes and hepatoma cells 8. L-Glutaminase has received significant attention recently, owing to its potential applications in medicine as an anticancer agent and in food industries 9-10. Microbial glutaminase have found application in several fields 11. It has been tried as therapeutic agent in the treatment of cancer 2, 10 and HIV 12. It is also used as an analytical agent in determination of glutamine and glutamate 14.
However one of the major use of microbial glutaminase in the food industry as a flavour enhancing agent 15. L- glutaminase is generally regarded as a key enzyme that controls the delicious taste of fermented foods such as soy sauce 16. The gamma glutamyl transfer reactions of L-glutaminase is also useful in the production of the high marketed value specialty chemicals like threonine 14. To our knowledge, the reports on production of L- glutaminase from P. expansum are scanty. In recent years, L-Glutaminase in combination with or as an alternative to L-asparginase could be used as in enzyme therapy for cancer particularly leukemia14. Several attempts were made to produce glutaminase through genetic engineering.
This review focuses on various conditions implemented for the production of L-Glutaminase, in sub-merged fermentation and solid state fermentation, physiochemical characteristics and applications of L-Glutaminase. Biochemical characteristics and purification aspects of the enzyme are dealt with briefly. The aim of the review is to give an overview on microbial production of L-Glutaminase, hitherto.
FIG. 1: SYSTEMIC REPRESENTATION OF MECHANISM OF ACTION OF L-GLUTAMINASE
Occurrence and Distribution: L-Glutaminase plays a major role in the nitrogen metabolism of both prokaryotes and eukaryotes 18. It is found to be widely distributed in plants, animal tissues and microorganisms including bacteria, yeast and fungi 19, 20. L-Glutaminase synthesis have been reported from many bacterial genera, particularly from terrestrial sources like E. coli 21, Pseudomonas sp22, Acinetobacter 23 and Bacillus sp 24. Although glutaminase have been detected in several bacterial strains, the best characterised were from members of Enterobacteriaceae family.
Among them E. coli, glutaminase have been studied in detail 21. However other members such as Proteus morganni, P. vulgaris, Xanthmonas juglandis, Erwnia carotovora, E. aroideae, Serratia marcescens, Enterobacter coacae, Klebsiella aerogenes and Aerobacter aerogenes 25, 19, 26 were also reported to have glutaminase activity. Among other groups of bacteria, species of Pseudomonas, especially, P. aeruginosa 27, 28 P. aureofaciens 19, P. aurantiaca 22, 29, and P. jluorescens 20 are well recognised for the production of glutaminase. All these strains have been isolated from soil.
Among Yeasts, species of Hansenula, Cryptococcus, Rhodotorula, Candida scottii 19 especially Cryptococcus albidus 19, 20, 30.
Cryptococcus laurentii, Candida utilis and Torulopsis candida were observed to produce significant levels of glutaminase under submerged fermentation. Saccharomyces cerevisiae was also shown to produce glutaminase 31. Species of Tilachlidium humicola, Verticillum malthoasei and fungi imperfecti were recorded to possess glutaminase activity 19. Glutaminase activity of soy sauce fermenting Aspergillus sojae and A. oryzae were also reported 32.
Marine Microorganisms as source of L-Glutaminase: Reports on the synthesis of extracellular L-Glutaminase by marine microorganisms are very limited to marine bacteria including Pseudomonas jluorescens, Vibrio costicola and Vibrio cholerae 33, 34 and Micrococcus luteus 35 and marine fungi Beauveria bassiana 36 only.
Biological Role of L-Glutaminase in Normal Cells and Tumor Cells: Cancer cells, especially acute lymphoblastic leukemia (ALL) cells cannot synthesize L-Glutamine and hence demand for large amount of L-Glutamine for its growth. The use of amidases deprives the tumor cells from L- glutamine and causes selective death of L-Glutamine dependent tumor cells. L-Glutaminase can bring about degradation of L-Glutamine and thus can act as possible candidate for enzyme therapy.
Cancer cells require a robust supply of reduced nitrogen to produce nucleotides, non-essential amino acids and a high cellular redox activity. Glutamine provides a major substrate for respiration as well as nitrogen for the production of proteins, hexosamines, and macromolecules. Therefore, glutamine is one of key molecules in cancer metabolism during cell proliferation.
The notion of targeting glutamine metabolism in cancer, originally rationalized by the number of pathways fed by this nutrient, has been reinforced by more recent studies demonstrating that its metabolism is regulated by oncogenes. Glutamine can exert its effects by modulating redox homeostasis, bioenergetics, nitrogen balance or other functions, including by being a precursor of glutathione, the major non-enzymatic cellular antioxidant.
Glutaminase (GA) is the first enzyme that converts glutamine to glutamate, which is in turn converted to alpha-ketoglutarate for further metabolism in the tricarboxylic acid cycle. Different GA isoforms in mammals are encoded by two genes, Gls and Gls2.
As each enzymatic form of GA has distinct kinetic and molecular characteristics, it has been speculated that the differential regulation of GA isoforms may reflect distinct functions or requirements in different tissues or cell states. GA encoded by Gls gene (GLS) has been demonstrated to be regulated by oncogenes and to support tumor cell growth. GA encoded by Gls2 gene (GLS2) reduces cellular sensitivity to reactive oxygen species associated apoptosis possibly through glutathione-dependent antioxidant defense, and therefore to behave more like a tumor suppressor. Thus, modulation of GA function may be a new therapeutic target for cancer treatment 37.
Media Optimization for Production of Glutaminases: Many studies have been done to optimize cultural conditions for L- Glutaminase production both in batch and continuous fermentation. Production of this enzyme depends on various parameters like concentration of carbon and nitrogen sources, pH of culture medium, temperature, fermentation time and oxygen transfer rate. It has been observed that these parameters vary for different organisms.
Properties of various microorganisms are mentioned in Table 1. Glutaminase is mostly obtained by submerged fermentation.
Effect of Additional Carbon and Nitrogen Sources on L-Glutaminase Production: Many L-Glutaminase producing microorganisms utilizes L-glutamine as both carbon and nitrogen sources and supplementation of any other carbon and nitrogen sources altered the L-Glutaminase production in most of the L-Glutaminase production fermentations. However, it was reported that addition of glucose enhanced the enzyme production in C. nodaensis 38, Pseudomonas sp. 39, Streptomyces rimosus 40, Providencia sp. 41, T. koningii 42 and Beauveria sp. 17 Contradicting report on glucose – mediated suppression of the L-Glutaminase production in Achromobacteraceae 43, S. maltophilia NYW-81 45 was also reported. Sucrose (Z. rouxii) and sorbital (B. bassiana BTMF S10) also supported L-Glutaminase production in addition to glucose.
This could be confirmed based on the fact that addition of these carbon sources resulted in enhanced L-Glutaminase production; Iyer and Singhal 36. Different carbon sources namely glucose, maltose, sucrose, fructose, lactose and soluble starch at 1% (w/v) were added to the basal solid state fermentative medium of A. oryzae and they have exerted a considerable effect on the biosynthesis of L-Glutaminase. The maximum enzyme production was promoted by glucose followed by lactose and maltose.
The enhanced production of L-Glutaminase by the incorporation of glucose to the medium may be attributed to the positive influence of glucose as a co-metabolic agent 46 for enhanced enzyme biosynthesis. These results were similar to those reported by production by Vibrio costicola by Prabhu and Chandrasekaran 10. And by Beauveria sp by Sabu et al., 17 Trichoderma koningii by Ashraf et al. 47
Most of the L-Glutaminase producing microorganisms utilize the complex organic nitrogen sources rather than inorganic sources for effective enzyme production. It was noticed that addition of yeast extract enhanced the L-Glutaminase secretion by C. nodaensis 38, B. bassiana BTMF S10 36 and Z. rouxii 48, 49. While Siva kumar et al., 45 observed that S. rimosus prefers the malt extract for higher L-Glutaminase production. Apart from complex nitrogen sources, inorganic nitrogen compounds such as ammonium sulphate and urea enhanced the enzyme production in Achromobacteraceae and Providencia sp. respectively 43. However, Prabhu and Chandrasekaran 10 and Sabu et al., reported that none of the additional nitrogen source enhances the L-Glutaminase production in solid state fermentation 13, 17. Among the various nitrogen sources, sodium nitrate in the medium promoted enhanced growth of microorganism and consequently the L-Glutaminase production, followed by malt extract and yeast extract .
These results were in similar to those reported by Prashanth Kumar et al. 50 Incorporation of additional nitrogen sources enhance glutaminase yield. Among various nitrogen sources tested ammonium acetate was the best nitrogen source promoted maximum yield 853.84 U/ml for the Mucor racemosus strain. The least enzyme yielding nitrogen source was found to be sodium nitrite with an enzyme production of 538.46 U/ml 51.
The supplementation of additional nitrogen sources (either organic or inorganic) such as ammonium nitrate, ammonium sulphate, sodium nitrate, malt extract, yeast extract, urea and peptone had shown a profound impact on the production of L-Glutaminase by A. oryzae 52. Among the various nitrogen sources, sodium nitrate in the medium promoted enhanced growth of microorganism and 45.19U/gds of L-Glutaminase production was observed. These results were in similar to those reported by Prashanth Kumar et al., (2009) 50.
Effect of pH: The pH and temperature tolerance of glutaminase from various microorganisms differed greatly. While optimal activities of glutaminase A and B of P. aeroginosa were at alkaline pH of 7.5-9.0 and 8.5 respectively 53, glutaminase from Pseudomonas sp was reported to be active over a broad range of pH (5-9) with an optimum near pH 7.0 54. Glutaminase of Pseudomonas acidovorans showed optimum activity at pH 9.5 and retained 70% activity at pH 7.4 55.
An intracellular glutaminase from Cryptococcus albidus preferred an optimal pH of 5.5- 8.5 20.Whereas, glutaminase 1 and 11 isolated from marine Micrococcus luteus were active at alkaline pH values of 8.0 and 8.5 respectively 35.
Glutaminase from A. oryzae and sojae recorded pH optima of 9.0 and 8.0 respectively 56. The intra and extracellular glutaminase from A. oryzae were most active and stable at pH 9.0 9. Glutaminase isolated from Penicillium brevicompactum NRC 829 showed its maximal activity against L-glutamine when incubated at pH 8 57.
Effect of Temperature: Microbial L-Glutaminase production is generally noticed at mild incubation temperature conditions ranging from 25 to 37 ºC. The temperature stability of glutaminases also showed wide variation. Glutaminase from Pseudomonas showed maximum activity at 37 ºC and were unstable at high temperatures 58, whereas, the enzyme from Clostridium welchii retained activity up to 60 ºC 59. Glutaminase from Cryptococcus alhidus retained 77% of its activity at 70°C even after 30 minutes of incubation 20.
Glutaminase I & II from Micrococcus luteus had a temperature optima of 50°C and the presence of NaCl (10%) increased the 16 thermo stability 35. The optimum temperature for activity of both intra and extracellular glutaminases from A. oryzae was 45 °C while they became inactive at 55 °C 9. Glutaminase isolated from Penicillium brevicompactum NRC 829 showed its maximal activity at 50 ºC, further increase in temperature at 70 ºC retained its activity indicates its thermostable nature 57. L-Glutaminase obtained from Aspergillus oryzae revealed optimum activity in a temperature range of 37 to 45 ºC 61.
L-Glutamine was highly deamidated at 60 ºC by glutamine amydohydrolase enzyme partially purified from Penicillium politans NRC 510 60. Glutaminase isolated from P. brevicompactum NRC 829 indicated that no significant enzyme activity was lost when it was pre incubated at 50 ºC to 60 ºC for 60 min. L-Glutaminase retained about 92% of initial activity after incubation (in the absence of substrate) at 70 ºC for 30 min. Moreover, L-Glutaminase was still retaining about 66% of the original activity, after incubation at 80 ºC for 5 min, which revealed the high thermal stability of L-Glutaminase.
These results indicate the thermophilic nature of the purified amidase enzyme produced by P. brevicompactum NRC 829 57. L-Glutaminase purified from Aspergillus oryzae is stable up to 45ºC but lost its activity completely at 55 ºC 61. Prusiner et al., 21 performed the E. coli L-Glutaminase stability studies at low temperatures and the authors observed that the exposure of enzyme to cold temperatures resulted in a reversible inactivation of enzymatic activity, while subsequent warming to 24 ºC restored the activity and no protein denaturation occurred during this process.
Effect of Sodium Chloride: Sodium chloride was found to influence the activity of glutaminase from both fungi and bacteria of terrestrial origin. Salt tolerant capacity of various microorganisms is given in Table 2. Glutaminase from E. coli, P. fluorescence, Cryptococcus albidus and A. sojae showed only 65, 75, 65 and 6% respectively of their original activity in presence of 18% NaCl 20. Similar results were obtained with glutaminase from Candida utilis, Torulopsis candida and A. oryzae 31. Salt tolerant glutaminase have been observed in Cryptococcus albidus and Bacillus subtilis 62, 63.
Glutaminase I and II with high salt tolerance was reported from Micrococcus Iuteus K-3 35. High salt-tolerance of L-Glutaminase produced by Lactobacillus rhamnosus was reported 64,65 where the presence of 5% (w/v) salt increased L-Glutaminase activity almost two-fold and 90% of the initial activity still remained at 15% (w/v) salt. On the other hand, L- glutaminases from other sources (Aspergillus oryzae) are markedly inhibited by high salt concentrations as demonstrated by Yano et al and Sabu A. et al., 2000 9, 17.
Effect of Various Substances and Heavy Metals: Glutaminase activity was found to be inhibited by various substances and heavy metals. Cetavlon, while accelerating glutaminase of Clostridium welchii, E. coli and Proteus moranii in crude extracts and intact cells, inhibited the purified enzyme 66. Glutaminase of E. coli was found to be sensitive to heavy metals 4 and Acinetobacter glutaminase-asparaginase was inactivated by glutamine analogue 6-diazo 5-oxo L-norleucine even at very low concentration while unaffected by EDTA, NH3, L-glutamate or L-aspartate 43.
Various investigations have shown that glutaminase from Pseudomonas was activated by certain divalent anions and cations while inhibited by monovalent anions and by certain competitive inhibitors like NH3, D and L-glutamic acid and 6-diazo 5-oxo L-norleucine 53. In the case of fungi both intra and extracellular glutaminase from Aspergillus oryzae were inhibited by Hg, Cr and Fe but were not affected by sulphydroxyl reagents. EDTA, Na2SO4, and p-c Woromercuribenzoate strongly inhibited the Micrococcus luteus glutaminase I while glutaminase II was inhibited by EDTA, HgCh, Na2SO4, CuCh and FeCh 39.
In case of glutaminases isolated from P. brevicompactum Among, considerable loss of activity was observed only with Hg2+ and Cu2+ while Na+ or K+ acting somehow as an enhancer . EDTA has no effect on enzyme activity which indicates that L-Glutaminase might not be a metalloenzyme. L-Glutaminase is neither inhibited nor activated by reducing agents compounds including 2-mercaptoethanol (2-ME) and reduced glutathione (GSH) or thiol group blocking (namely iodoacetate) which indicates the absence of evidence for the involvement of SH group(s) in the catalytic site of this enzyme 57.
TABLE 1: PROPERTY OF L-GLUTAMINASES FROM VARIOUS MICROORGANISMS
|S. no.||Microorganism||Optimum pH||Optimum Temperature (oC)||Molecular weight
|1||Escherichia coli||5||NR||100 28||L-Glutamine,γ-L Glutamylmethylamide,γ-Glutamyl-hydrazide,γ-L-Glutamylhydroxamate,γLGlutamyl-methoxyamide γ-LMethylLglutamate,γ-L-Ethyl-L-glutamate,γ-L-Thiomethyl-L-glutamateγ-L -Thioethyl-L glutamate 4, 67, 68|
|2||Acinetobactr glutaminasificans||7||NR||132 33||L-Glutamine D-Glutamine L-Asparagine D-Asparagine γ-L-Glutamyl-hydroxamate 43, 67|
|3||Bacillus subtilis||6||50||55||L-Glutamine D-Glutamine 63|
|4||Pseudomonas aeruginosa||7.5-9||NR||137 35||L-Glutamine D-Glutamine L-Asparagine D-Asparagine 53|
|5||Pseudomonas aurantiaca||6.8-8||NR||148 47||L-Glutamine L-Asparagine 19|
|6||Pseudomonas fluorescens||7||37||glucose, sucrose, maltose, lactose and mannitol, L-tyrosine, L- lysine, L-asparagine and L- glutamic acid 11|
|7||Escherichia coli||7.1-7.9||NR||90 35||L-Glutamine γ-L-Glutamyl-hydroxamate 21|
|8||Pseudomonas aeruginosa||8.5||NR||67||L-Glutamine, D-Glutamine , L-Theanine , D- Theanine γ-L-Glutamyl-hydrazide 28|
|9||Bacillus pasteurii||9||37||100 55||L-Glutamine , D-Glutamine, L-Asparagine 9|
|10||Rhizobium etli||NR||NR||106.8 26.9||L-Glutamine 16|
|11||Micrococcus luteus I||8||50||86 43||L-Glutamine , γ-L-Methyl-L-glutamate , γ-L-Ethyl-L-glutamate , γ-L-Thio methyl-L-glutamate , γ-L -Thio ethyl-L-glutamate 35|
|12||Micrococcus luteus II||8.5||50||86||L-Glutamine 35|
|13||Pseudomonas nitroreducens||9||NR||40||L-Glutamine D-Glutamine DL-Theanine Glutathione 69|
|14||Stenotrophomona s maltophilia NYW- 81||9||60||41||L-Glutamine D-Glutamine L-Asparagine D-Asparagine 45|
|15||Yeast 14 Debaryomyces sp||8.5||40||115 50,65||L-glutamine 64|
|16||Fungi Aspergillus oryzae MA-27-IM||9||45||113||L-Glutamine D-Glutamine 70|
|17||Aspergillus oryzae AJ11728||9||37-45||82||L-Glutamine, D-Glutamine 71|
|18||Penicillium politans NRC 510||8||60||133||L-asparagine , D-asparagine , L-glutamine , D-glutamine Nicotinamide , Nicotinamide adenine ,dinucleotide ,Acetamide 72|
|19||Penicillium brevicompactum||8.5||50||71||L-Asparagine, L-Glutamine , D-Asparagine , D-Glutamine , NAD Acetamide , Acrylamide 57|
NR = Not reported
TABLE 2: SALT TOLERANCE OF L-GLUTAMINASES PRODUCED BY VARIOUS MICROORGANISMS
|S. no.||Microorganism||Residual activity (%)||NaCl concentration (%)||References|
|7||Micrococcus luteus I||130||16||35|
|8||Micrococcus luteus II||100||16||35|
|11||Penicillium politans NRC 510||75||20||75|
|13||Vibrio SP. M9||28.7 U/ml||3.5||76|
NR = Not reported
Production of L-glutaminase by SSF: In recent years, SSF has been emerged as a promising technology for the development of several bioprocesses and products including the production of industrial enzymes on a large scale. The primary advantage of SSF is the fact that many metabolites are produced at higher concentration.
Marine microorganisms which are salt tolerant and have the potential to produce novel metabolites are highly suitable for use in SSF by virtue of their rare availability to absorb on to solid support particles.
Some reports suggests that polystyrene, commercially available insulating and packaging material, could be used as an inert solid support for the production of L-Glutaminase by a marine Vibrio casticola under SSF while ion exchange resins, polyurethane foam and computer cards have been used as inert carriers for SSF with fungi. Prema Kashyap et al., reported 77 the production of extracellular L-Glutaminase by the halophilic yeast Zygosaccharomyces rouxii under solid- state fermentation, even though there was no report on the production of L-Glutaminase by any yeast under SSF using agricultural by products.
In their study they have evaluated several agricultural waste materials as substrates.
They concluded the importance of utilization of natural substrates, viz. wheat bran and sesamum oil cake for the production of glutaminase enzyme. Their study showed that the yield should be increased for industrial use, and this proved the feasibility of SSF and agro-industrial residues for L-Glutaminase production.
Table 3 depicts the various organism and solid substrates used for the production of L-Glutaminase. Renu et al., 34 compared the L-Glutaminase production in submerged fermentation with solid-state fermentation. The authors observed that solid-state fermentation was preferable to submerged fermentation for L--glutaminase production in terms of yield efficiency, since 25 to 30 fold increase in enzyme production was obtained under solid state fermentation.
For the production of L-Glutaminase in solid state fermentation various agro industrial materials were used as solid support.
Many authors reported that wheat bran was found to be a preferable support for enzyme production 10, 77. Apart from the wheat bran, rice bran, copra cake powder, ground nut cake powder and sesamum oil cake were used as solid substrates for enzyme production 10. However Polystyrene beads, impregnated with mineral salts and glutamine were used as solid substrate for glutaminase production. Renu and Chandrasekaran 34 observed that Pseudomonas fluorescens, Vibrio cholerae, and Vibrio costicola, from among the strains screened from marine environments of Cochin, produced L-Glutaminase extracellularly in copious amounts. Process conditions for large-scale production of this enzyme were optimized in solid-state fermentation.
The authors studied the impact of operational parameters on L-Glutaminase production by V. costicola, and it was observed that maximum enzyme production was achieved in a wheat bran medium containing particles 1.4 to 2.0 mm in size and under optimal conditions which were: a moisture content of 40 to 60 %, pH 6.0, incubation at 35 °C, and with the addition of glutamine at 1.0% (w w-1).
Later Prabhu and Chandrasekaran 10 observed that during solid state fermentation production of L-Glutaminase by V. costicola also simultaneously produced alpha-amylases and cellulases. The authors inferred that wheat bran, which was used as solid substrate, may have been used as substrate and brought about the induction of synthesis of alpha-amylase and cellulase. L-Glutaminase was found to be induced by L-glutamine. The authors later observed that V. costicola could grow on an inert carrier such as Polystyrene beads, impregnated with mineral salts and glutamine and produce enzyme under solid-state fermentation 10.
The ability to absorb onto polystyrene appears to be a basic property of marine bacteria. In their natural environment, many species of marine bacteria exist only under adsorbed conditions on detritus or solid substrates. In another investigation by Prabhu and Chandrasekaran 10, the best process parameters influencing L-Glutaminase production by marine V. costicola in solid-state process using polystyrene as an inert support were optimized. Maltose and potassium dihydrogen phosphate enhanced enzyme yield by 23% and 18%, respectively, while nitrogen sources had an inhibitory effect. As in the earlier study, leachate with high L-Glutaminase specific activity and low viscosity was recovered.
In the study by Sabu et al., the potential of Beauveria sp. for L-Glutaminase production using polystyrene as solid support under solid-state process was evaluated 17. Future Kashayp et al., 77 was produced the L-Glutaminase by the saline tolerant yeast Z. rouxii NRRL-Y 2547 using two agro-industrial substrates, wheat bran and sesamum oil cake.
The authors observed that NaCl medium for wheat bran and seawater for sesamum oil cake is suitable for moisturizing liquid. Higher L-Glutaminase titres (7.5 and 11.61 U gds-1 for wheat bran and sesamum oil cake, respectively) were produced when SSF was carried out with 64.2% initial moisture content of the substrate, 2 ml of inoculum, and 30 ºC as incubation temperature. External supplementation of fermentation medium with various organic and inorganic nitrogen sources was of no benefit for enzyme production. In recent studies by Sayed found that wheat bran was the best solid substrate for induction of the L-Glutaminase by Trichoderma koningii. The maximum yield (45 U gds-1) of L-Glutaminase by T. koningii occurred using wheat bran of 70% initial moisture content, initial pH 7.0, supplemented with D-glucose (1.0%) and L-glutamine (2.0% w/v), inoculated with 3 ml of culture and incubated at 30 °C for 7 days.
TABLE 3: VARIOUS FERMENTATION PARAMETERS FOR THE PRODUCTION OF L-GLUTAMINASE IN SOLID STATE FERMENTATION
|S. no.||Organism||Solid Substrate||Medium pH||Incubation temperature (ºC)||Activity|
|1||Vibrio costicola ACMR 267||Polystyrene beads 10||7||35||232.00 U gds-1|
|2||Beauveria sp. BTMFS 10||Polystyrene beads 17||9||27||49,890.00 U L-1|
|3||Zygosaccharomyces rouxii NRRL-Y 2547||Wheat bran and sesame oil cake 77||NR||30||7.50 and 11.61 U gds-1|
|4||Actinomucor elegans||Soya bean curd 78||NR||25||176.00 U gds-1|
|5||Rhizopus oligosporus||Soya bean curd 78||NR||35||187.00 Ugds-1|
|6||Trichoderma koningii||Wheat Bran 42||7||30||45 Ugds-1|
|7||Aspergillus oryzae NCIM||agro residues including wheat bran, rice bran, etc. 52||7||30||27.76 U/gds|
|8||Aspergillus flavus||agro- industrial by-products like wheat bran, rice bran or wheat 79||4||30||15.59 U/gds|
|9||Serratia marcescens||Rice bran 80||7.17||37.04 ºC,||193.10 IU/ml.|
|10||Bacillus amyloliquifaciens||agro- industrial by-products 81||5||60||196.2|
|11||Mucor racemosus 51||7||25||969.23 U/ml. T|
|12||Pseudomonas stutzeri P||agro-industrial waste like green gram husk, Bengal gram husk, cattle feed, wheat bran and groundnut cake 83||7||37||95.2IU|
NR = Not reported
Submerged Fermentation: Table 4 shows the various bacteria, fungus and yeast used for the production of the L-Glutaminase. Roberts et al 43 isolated the Achromobacteraceae from the soil samples and observed that the enzyme from this organism has L-Glutaminase and L-asparaginase activity in a ratio of 1.2:1.
The highest yields of enzyme are obtained when cells are grown aerobically in a basal synthetic medium composed of L-glutamic acid, ammonium sulfate, trace minerals, and phosphate buffer.
The authors observed that the temperature between 15 to 25 ºC is favourable to the organism growth and enzyme production. Extracellular L-Glutaminase producing Beauveria sp. BTMF S10 was isolated from marine sediment. The authors observed that this enzyme was inducible and growth associated. The highest yield (46.9 U ml-1) is obtained in a medium supplemented with 1% yeast extract and sorbitol 9% sodium chloride and 0.2% methionine at medium initial pH 9.0 and 27 °C. L-Glutaminase production by Stenotrophomonas maltophilia NYW-81 was optimized by Wakayama et al. 45
The highest yield was obtained at pH 7.0 and at 30°C temperature. The authors observed that when glutamine is used a sole carbon and nitrogen source the production is high. When glucose is added to the medium it suppresses the L-Glutaminase production in S. Maltophilia 45. Keerthi et al., 82 observed that the L-Glutaminase produced from actinomycetes has a good salt tolerance. They isolated the 20 strains from estuarine fish and observed that Streptomyces rimosus was showed highest L-Glutaminase activity. Optimum production of L-Glutaminase was observed at incubation temperature at 27oC, pH 9.0 and glucose and malt extract as carbon and nitrogen sources respectively.
In various investigations of Iyer and Singhal (2008, 2009) 48 observed that the carbon and nitrogen sources for L-Glutaminase production are varied with the organisms. Supplementation of sucrose and yeast extract as carbon and nitrogen source revealed improved L-Glutaminase production frin Zygosaccharomyces rouxii. While, higher L-Glutaminase production noticed from Providencia sp. with supplementation of glucose and urea as carbon and nitrogen sources. Jambulingam Kiruthika1 et al., 84 studied L-Glutaminase production pattern under submerged fermentation using novel marine isolate Vibrio azureus strain JK-79 (GenBank Acession Number JQ820323).
It was seen that maximum yield of enzyme production (247 U/ml) was achieved in a seawater based medium at pH 8, 37 °C, 1% inoculum concentration and 2% glutamine concentration for 24 h. The medium when supplemented with carbon source, it improved the enzyme production from 247 to 321 U/ml with 1.5% maltose. Addition of 2% soybean meal also improved the L- glutaminase production (289 U/ml).
Jeong-Min Jeon et al., 85 isolated glutaminase gene from L. reuteri KCTC359, cloned it by PCR, and subsequently introduced into two Korean isolates of Lactobacillus species. All the transformants harboring the glutaminase gene from L. reuteri KCTC3594 were able to elevate glutaminase activity.
TABLE 4: VARIOUS FERMENTATION PARAMETERS FOR THE PRODUCTION OF L-GLUTAMINASE IN SUBMERGED FERMENTATION
|S. no.||Organism||Carbon and
|Incubation temperature (ºC)||Activity
|L Glutamic acid 2.0% and ammonium sulphate 50.4%||7.2||25||130.00 U L-1|
|2||Aspergillus oryzae S 2 44||Dextrose 0.1%, yeast extract 0.3%, Kcl 0.02%, Nacl 0.01%, Mgcl2 0.02%, starch 0.5% w/v.||5||35||217.65
|3||Cryptococcus nodaensis 38||D-Glucose 3.0% and yeast Extract 0.5%||6.0||28||2060.00 U L-1|
|4||Beauveria bassiana BTMF S10 36||L-Glutamine 1.0 %, yeast extract 1.0% and sorbitol 1.0||9||27||46,900.00 U L-1|
|5||Pseudomonas sp BTMS-51 39||L-Glutamine 2.0 % and D-glucose- 1.0 %||6||30||36,050.00 U L-1
|6||Stenotrophomonas Maltophilia NYW-81 45||L-Glutamine 1.0 %||7||30||32,000.00 U L-1|
|7||Streptomyces rimosus 40||L-Glutamine 1.0%, Glucose 1.0% and Malt extract 1.0%||9||27||17,510.00 U L-1
|8||Zygosaccharomyces rouxii NRRL-Y 2547 48||Sucrose 1.78%, yeast extract 4.8% and glutamine 0.5%||7||37||458.68 U L-1|
|9||Providencia sp 41||Glucose 1.0 % and urea 0.5%||8||25||119.23 U L-1|
|10||Zygosaccharomyces rouxii NRRL-Y 2547 49||Sucrose 1.78%, yeast extract 4.8% and glutamine 0.5%||7||37||437.14 U L-1,|
|11||Vibrio SP. M 976||0.5 KCl, 0.5 MgSO4, 1.0 KH2PO4, 0.1 FeSO4, 0.1 ZnSO4, 10 glutamine||7||35||28.7 U/ml|
|12||Streptomyces avermetilis||Glucose, sodium nitrate, 4% NaCl, MgSO478||8||28||39.3 U/mg|
|13||Penicillium politans NRC 510||HgCl2, NaF, CaCl2, BaCl2 and CuSO4 75||8||60||133 U/mg.|
|14||Vibrio azureus JK-79||2% glutamine concentration, 1.5% maltose, 2% soybean meal 84, 87||8||37||321 U/ml.|
NaCl (w/v) and 1% malt extract (w/v) , 1% glucose (w/v) 88
|16||Streptomyces labedae||1.0 KH2PO4, 0.5 MgSO4; 0.1 CaCl2, 0.1 NaNO3, 0.1Na3C6H5O7, 25 NaCl, 10 glucose 89||7-8||30||12.23U
Desirable Properties of Glutaminase Enzymes for Therapeutic Use: Glutaminase enzymes according to the present invention are therapeutically suitable if they display high enzyme activity at physiologic pH, i.e., between about pH 6.5 and 8.5. Therapeutically suitable glutaminase enzymes must have a low KM, i.e., between 10−6 and 10−4 M. Additionally desirable properties of glutaminase enzymes for therapeutic use include:
- High stability at physiologic p H.
- Retains high activity and stability in animal and human sera and blood.
- Cleared slowly from the circulation when injected into animals or humans. A plasma half-life (t½) for glutaminase greater than six hours in mice and sixteen hours in humans is desirable.
- Not strongly inhibited by the products of the reaction it catalyzes or by other constituents normally found in body fluids.
- Does not require cofactors or prosthetic groups that can easily dissociate from the enzyme.
- Narrow substrate specificity.
- Effective irreversibility of the enzymatic reaction under physiologic conditions.
- Available from an organism that contains low levels of endotoxin.
- Low immunogenicity.
A number of amino acid-degrading enzymes that do not exhibit antitumor activity also fail to meet at least one of these criteria. For instance, E. coli glutaminase has a pH optimum of 5 and essentially no activity at physiologic pH. An ineffective form of E. coli asparaginase has a KM over 1 mM. Asparaginase enzymes from yeast, Bacillus coagulans, and Fusanium tricinctum all have excessively rapid clearance rates in mice. The known mammalian glutaminase enzymes are not suitable for use as therapeutic agents because of their high KM values (millimolar range), and their requirement for phosphate esters or malate for activation.
The E. coli glutaminases (A and B) are also unsuited for therapeutic use because of their high KM values (millimolar range), low activity at physiological pH (glutaminase A), or requirement for special activating substances (glutaminase B).
One of the most promising therapeutic applications ever proposed for L-Glutaminase is in the treatment of HIV 39. Roberts et al have patented a therapy for HIV, where L-Glutaminase from Pseudomonas sp. 7A is administered so as to inhibit HIV replication in infected cells. The enzyme brings about inhibition of tumour (melanoma) and DNA biosynthesis in affected cells 12.
Applications of L-Glutaminase: Microbial L-Glutaminases have found several potent applications in various industrial sectors in the recent years. The enzyme, though originally identified as a potent anti-cancer drug with possible applications in enzyme therapy, has been used in food industry for flavour enhancement. Recent applications of the enzyme include its use in biosensors and in the manufacture of specialty chemicals by enzymatic transformations. The important applications are discussed below under the categories- therapeutic applications, applications in food industry, analytical applications, and manufacture of fine chemicals.
Glutaminase and its Development as a Chemotherapeutic Agent: High rate of glutamine consumption is a characteristic nature of some types of cancerous cells 90. Based on this character experimental therapies have been developed to deprive L-glutamine to tumour cells; Rosenfold and Roberts Keerthi 91, 48. Tumour growth regulation can be achieved by inhibition of both protein and nucleic acid biosynthesis in the cancerous cells due to the lack of availability of any component of these macromolecules. Inhibition of the tumour cell uptake of glutamine is one of the possible ways to stop the growth and this is the best accomplished by the use of L-Glutaminase, which breaks down L-glutamine. This in fact, results in a selective starvation of the tumour cells because unlike normal cells they lack properly functioning glutamine biosynthetic machinery 92.
Several studies were made towards using L-Glutaminase in cancer therapy 2, 93, 94, 95, 96, 97. Warrell et al., 98 used the L-Glutaminase against adult leukemia. One of the major problems encountered in the treatment with microbial L-Glutaminases is the development of immune responses against the enzyme. Also the enzyme introduced intravenously has to act at the tumour site within the short span of time it remains in circulation before being cleared at the kidneys.
In order to avoid the above problems associated with L-Glutaminase mediated treatment of certain types of cancers, several investigations were made. The problems faced in clinical application of A. glutaminase as a drug in the treatment of leukaemia was described by Spires et al. 96
Holchenberg described the human pharmacology and toxicology of A. glutaminase. Jaafar Belgoudi, attempted immobilization of the enzyme in polyethylene glycol and found that the enzyme showed optimal activity over a larger pH range which was due to the matrix effect 99. Giordano et al., 100 proposed an extracorporeal administration of the enzyme in acute lymphoblastic leukemia. However, it may be noted that alternative methods for tumour cells are coming up which include the use of phenyl acetate to deplete glutamine 101, 102 and the use of gene therapy. Phenyl acetate was proposed as a drug in the treatment of human cancer even before 30 years 103. The latter approach was recently tried by the use of an antisense mRNA for phosphate activated L-Glutaminases in Ehrlich ascites tumour (one type of breast carcinoma) 104. Such improvements in cancer therapy may soon obviate the role of microbial L-Glutaminases as an anti-tumour drug.
Ali Mohamed Elshafeil et al., 57 isolated glutaminase from Penicillium brevicompactum NRC 829. Using MTT assay, the in vitro bioassay cytotoxic effect of Penicillium brevicompactum NRC 829 L-Glutaminase on the growth of four human tumor cell lines namely Hep-G2 [Human hepatocellular carcinoma cell line], MCF-7 [Breast cancer cell line], HCT-116 [Colon cell line] and A549 [Human lung Carcinoma] showed that the crude-enzyme extracts have anti- proliferative activity in different cell lines growth. However, the highest antitumor activity was recorded towards Hep-G2 (65.3%), while the least activity was obtained towards A-549 (33%) when compared with the growth of untreated control cells.
One of the most promising therapeutic applications ever proposed for L-Glutaminase is in the treatment of HIV 39. Roberts et al., have patented a therapy for HIV, where L-Glutaminase from Pseudomonas sp. 7A is administered so as to inhibit HIV replication in infected cells. The enzyme brings about inhibition of tumour (melanoma) and DNA biosynthesis in affected cells.
Application of L-Glutaminase in Food Industry: L-Glutaminase is the most important amino acid in food manufacture for a delicious taste 105, 106. The pleasant and palatable tastes of oriental fermented foods like soy sauce, miso and sufu are considered to be related to the content of L-glutamic acid in them 107, 108, 109 accumulated due to the hydrolysis of a protein component catalysed by proteolytic enzymes, including L-Glutaminase, protease and peptidases 110.
Hydrolysis of glutamine by L-Glutaminase may also contribute significantly to the high content of L- glutamate in these products 111, 112, 113, 114. Several attempts were made to improve the quality of soy sauce and miso utilizing the action of microbial L-Glutaminases 108, 111, 114.
Koji mould with highly active L-Glutaminase was used for increasing the L-glutamate content of soy sauce by Yamamoto and Hirooka 112, whereas L-Glutaminase of C. albidus was used for the same purpose by Yokotusa et al., 20 and Iwasa et al. 62 In another method, the Japan Tokko Koho Company used peptidoglutaminase of B. circulans to improve the flavour of soy sauce 115.Whereas Chou and Hwan 114 used the L-Glutaminase from Actinomucor taiwanensis to increase the L-glutamate content of Sufu. Impressive studies were undertaken at the Kikkoman Corporation, Japan for production of glutaminase and its applications. Ushijima and Nakadai 116 used mutation and protoplast fusion techniques for improving L-Glutaminase production by A. sojae employed in shoyu fermentation.
Fukushima and Motai 106 achieved continuous production of L-Glutaminase in liquid seasoning using an immobilized C. albidus. Sato et al., 38 described a fermentation procedure for L-Glutaminase production by C. nodaensis in 30L fermenter and an effective method for purification of the enzyme. These processes for L-Glutaminase production and purification have been patented by the company, Sato et al., Several other reports are available on the use of microbial L-Glutaminases in food flavouring.
Processes for continuous conversion of glutamine to glutamate in food preparations, employing either immobilized L-Glutaminase or whole cells of L-Glutaminase producing microbes are also reported by industries and research institutions 117. Salt tolerant L-Glutaminases are most valuable in the industrial processes that require high salt environments like the soy sauce fermentation. L-Glutaminases from conventional sources (A. oryzae) are markedly inhibited by high salt concentrations as demonstrated by Yano et al. Salt tolerant L-Glutaminases were patented for use in industrial processes 17.
Moriguchi et al., 35 have proposed the use of salt tolerant L-Glutaminase from bacteria as a possible alternative, since their enzymes could be halophilic rather than halotolerant allowing for the use of high salt concentrations.
Analytical Applications: L-Glutaminase for biosensor application to determine the L-glutamine levels was investigated by Kikkoman Corporation, Japan, Sabu et al., Botre et al., Huang et al., Mulchandani and Bassi, 17,117,118,119,120 and hybridoma culture media 121 by flow injection analysis.
Analysis of L-glutamine and glutamate levels of the body fluids is important in clinical diagnostics and health monitoring. Enzymatic determination of glutamine and glutamate is more accurate and reliable compared to the older techniques like Nesslerization followed by determination of produced ammonia. Lund 14 described an efficient spectrophotometric method for determination of L-glutamine and L-glutamate using L-Glutaminase and L-glutamate dehydrogenase.
L-Glutaminases are used currently both in free enzyme or immobilized on membranes forms as biosensors for monitoring glutamine and glutamate levels of fluids. The application of L-Glutaminase in clinical analysis hassled to a tremendous boost in the search for L-Glutaminases which are stable over longer periods for use in biosensors, and companies have started to manufacturing highly purified L-Glutaminase enzyme specifically for this purpose.
However, the clinically used L-Glutaminases largely come from mammalian sources with a few exceptions.
One of the important producers of analytical grade microbial L-Glutaminase is the Kikkoman Corporation, Japan. This company produces L-Glutaminase using Bacillus sp. and uses in clinical analysis for determination of glutamine in conjunction with L-glutamate oxidase and peroxidase 17. An amperometric enzymes electrode probe with membrane immobilized L-Glutaminase was described by Villarta et al 117for determination of serum glutamine levels of humans.
Botre et al., 118 used L-Glutaminase based biosensor for determination of glutamine and glutamate in pharmaceutical formulations.
The enzyme has also been widely employed in the monitoring of glutamine and glutamate levels in mammalian cell culture media 119, 120 and hybridoma culture media 121 by flow injection analysis using biosensors.
Free enzyme was used in the determination of glutamine in insect cell culture media by Wang et al. 122 Important applications are also proposed for L-Glutaminase based biosensors in the online monitoring of fermentation 123, 124.
Manufacture of Fine-Chemicals: Theanine (γ-l-glutamyl ethylamide) is one of the major components of amino acids in Japanese green tea and unique as a taste-enhancing amino acid of infused green tea. Recently, increasing attention has been drawn towards the physiological roles of theanine, especially in a clinical point of view because of their ability to suppress stimulation by caffeine, to improve effects of antitumor agents, and their role as antihypertensive agents. In general theanine is synthesized by theanine synthetase (EC 188.8.131.52) in plants.
Tachiki et al., 125 have developed a method of producing theanine from glutamate and ethylamine using a combination reaction of bacterial glutaminases with baker’s yeast. Researchers at the Taiyo Kagaku Co., Ltd., Japan, devised a method for continuous production of threonine employing immobilized Pseudomonas nitroreducens as source of L-Glutaminase 126, 127.
The process reported a threonine yield of 95% on the basis of glutamine consumed. Another US patent entitled "a method for production of threonine using the L-Glutaminase from P. nitroreducenes" was granted to Sabu, 17.
Another most important emerging application of L-Glutaminase in industry comes from its use in the manufacture of γ -glutamyl alkamides. L-γ-glutamyl alkamides are prepared by γ-glutamyl transfer from a donor such as glutamine or glutathione to a glutamyl acceptor like ethylamine, methyl amine or glycyl glycine. L-Glutaminases are found to catalyze these reactions. Several processes based on the microbial L-Glutaminase catalyzed synthesis of γ-glutamyl alkamides have come up in the recent years.
Patents have been filled for the threonine production process employing L-Glutaminase from P. nitreducens, P. adapta and P. denitrificans and Bacillus sp. 17. Tachiki et al., 125 used the L-Glutaminase from P. nitroreducens for the production of γ-glutamyl-methylamide in addition to threonine by using methylamine as the of γ-glutamyl acceptor.
Commercial Production of Microbial L-Glutaminase: The researchers at Kikkoman Corporation, Japan performed some of the remarkable works on production of the enzyme. The research group at the company used mutation and protoplast fusion techniques for improving L-Glutaminase production by the koji mould, A. sojae, 116.
A submerged fermentation process for production of thermostable L-Glutaminase by C. nodaensis, and its purification was developed by the same company 38 and the process was patented.
TABLE 5: COMMERCIAL AVAILABLE MICROBIAL L-GLUTAMINASES
|S. no.||Manufacturer||Brand name||Source|
|1||Amano enzymes inc, Japan||Glutaminase F “Amano 100”||Bacillus subtilis|
|2||Biocatalysts, UK||Flavorpro B73P||Bacillus sp|
|3||Kikkoman Corporation, Japan||GLN||Bacillus sp|
|4||Ajinoto Co Inc, Japan||Glutaminase||Bacillus sp|
|5||Enzyme Development Corporation, Japan||Enzeco||Bacillus subtilus|
The company developed the production of enzyme from the yeasts Cryptococcus sp, Candida sp, Saccaromyces sp. and Sporromyces sp. The process claims to yield high titers of L-Glutaminase, which may be exploited commercially. Nevertheless currently the major industrial source of L-Glutaminase remains to be species of Bacilli. The Table 5 summarizes the L-Glutaminases available in the market.
CONCLUSION: Despite the promise of glutaminase as a therapeutic agent, there are currently no therapeutically useful glutaminases available which can be produced cheaply and with little or no contamination by other substances, for example by endotoxins of a host microorganism. Moreover, a suitable enzyme is not available in quantities which are large enough to allow for wide-spread clinical trials.
For a glutaminase to be ideally suited for use in antineoplastic therapy, it should satisfy a variety of criteria. The selected organism should produce the glutaminase in high yield, and it should be capable of being grown in large quantities on a simple and inexpensive medium. The procedures developed for purification of the enzyme should be as rapid and simplified as possible, providing pure enzyme in high yield. The purified enzyme should have long term stability on storage, maximal activity at a physiological pH, and a Km for substrate below the concentration of the substrate in the blood. .
Furthermore, a detailed understanding of the regulation of gene expression based on molecular approaches and other means would contribute immensely towards developing successful strategies for strain improvement which is a prerequisite for any industrially important enzyme. Although some patents had been developed. Further studies and regulatory approvals will enable the introduction of new glutaminase drugs with potential benefits to patients.
CONFLICT OF INTEREST: Nil
- Balagurunathan R, Radhakrishnan M and Somasundaram ST: L-Glutaminase producing actinomycetes from marine sediments–selective isolation, semi quantitative assay and characterization of potential strain. Aust J Basic Appl Sci 2010; 4: 698-05.
- Roberts J, Holcenberg JS and Dolowy WC: Antineoplastic activity of highly purified bacterial glutaminase. Nature 1970; 227: 1136- 37.
- Teja DD, Devi VS, Harsha N, Vishala SS and Lakshmi PKS: Production of L-glutaminase from marine ecosystems and optimal conditions for maximal production by actinomycetes. International Journal of Advanced Research 2014; 2(1): 485-91.
- Hartman S: Glutaminase (Escherichia coli). Meth Enzymol 1970; 17A (134): 941-45.
- Roberts J, Schmid FA and Rosenfeld HJ: Biologic and antineoplastic effects of enzymes- mediated in-vivo depletion of L-glutamine, L-tryptophan and L-histidine. Cancer Treat Rep 1979; 63(6): 1045-54.
- Tapiero H, Mathe G, Couvreur P and Tew KD: Free amino acids in human health and pathologies II, glutamine and glutamate. Biomed Pharmacother 2002; 56: 446-57.
- Rohde T, MacLean DA and Klarlund PD: Glutamine, lymphocyte proliferation and cytokine production. Sci J Immunol 1996; 44: 648-50.
- Souba WW: Glutamine and cancer. Ann Surg 1993; 218: 715-28.
- Yano T, Ito M, Tomita K, Kumagai H and Tochikura T: Purification and properties of glutaminase from Aspergillus oryzae. Journal of Fermentation Technology 1988; 66: 137-43.
- Prabhu GN and Chandrasekaran M: Impact of process parameters on L-Glutaminase production by marine Vibrio costicola under solid state fermentation using polystyrene as inert support. Process Biochemistry 1997; 32: 285-89.
- Chitanand MP and Shete HG: Condition optimization and production of extracellular l-Glutaminase from Pseudomonas fluorescens. International Journal of Pharma and Bio Sciences 2012; 3(3): B155-62.
- Roberts J, MacAllister TW, Sethuraman N and Freeman AG: Genetically engineered glutaminase and its use in antiviral and anticancer therapy, US patent. 2001 November 6; 6312939.
- Schamid FA and Roberts J: Antineoplastic and toxic effects of Acinetobacter and Pseudomonas glutaminase asparagines. Cancer Chemotherapy Rep 1974; 58(6): 829-40.
- Lund P: L-glutamine and L-asparagine, UV method with glutaminase and glutamate dehydrogenase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis 1986; 8: 357-63.
- Rajeev KS and Chanrdasekaran M: Continuous production of L- glutaminase by an immobilized marine Pseudomonas sp BTMS- 15 in a packed bed reactor. Process Biochemistry 2003; 38: 1431-36.
- Tomita K, Yano T, Kumagai H and Tochigura T: Formation of gamma glutmyl glycylglycine by extracellular glutaminase of Aspergillus oryzae. J of Fermentation Technol 1988; 66: 299-04.
- Sabu: L-Glutaminase production by marine Beauveria sp. under solid state fermentation Process Biochemistry 2000; 35(7): 705-10.
- Katikala PK, Bobbarala V, Prabhakar TP and Guntuku GS: Screening of L-glutaminase producing marine bacterial cultures for extracellular production of L-glutaminase. Int J Chem Tech 2009; 1: 1232-5.
- Imada A, Igarasi S, Nakahama K and Isono M: Asparaginase and glutaminase activities of microrganisms. J Gen Microbiol 1973; 76: 85-99.
- Yokotsuka T, Iwasa T and Fujii S: Species cryptococcus nodaensis, a process for producing salt-resistant thermostable glutaminase by use of the same, and a process for producing glutamic acid-rich protein hydrolysates. Nippon Shoyu Kenkyusho Zasshi 1987; 13: 18-25.
- Prusiner S and Stadtman ER: Regulation of glutaminase B in Escherichia coli- Modulation of activity by carboxylate and borate ions. J Biol Chem 1976; 251: 3457-62.
- Kabanova EA, Lebedeva ZI and Berezov TT: Thermostabilization of glutamin (asparagin)ase from Pseudomonas aurantica BKMB-548.
- Holchenberg T: Physical properties of Actinetobacter glutaminase -asparginase with antitumour activity by J Biol Chem 1972; 247: 7750-58.
- Cook: Occurrence of an inducible glutaminase in Bacillus licheniformis. J Bacteriol 1981; 148: 365-67.
- Wade HE, Robinson HK and Philips BW: Asparaginase and glutaminase activities of bacteria. J Gen Microbiol 1971; 69: 299-12.
- Novak and Philips: L-Glutamine as a substrate for L-asparaginase from Serratia marcescens. J Bacteriol February 1974; 117(2): 593-00.
- Greenberg DM, Blumenthal G and Ramadan MA: Cancer Res 1964; 24: 957.
- Ohshima M, Yamamoto T and Soda K: Effect of Glutamine analogs on glutaminase formation in Pseudomonas aeruginosa. Bull Inst Chem Res Kyoto Univ 1976a; 54: 170-75.
- Lebedeva ZI and Berezov TT: Improved method of purification and properties of glutaminase-asparaginase from Pseudomonas aurantiaca Bulletin of Experimental Biology and Medicine. November 1997; 124(5): 1156-58.
- Fukashima D: Fermented soya bean protein and related foods of Japan and china J Amer Oil Chemists Soc 1990; 56: 357-62.
- Soberon M and Gonzalez A: Physiological role of glutaminase activity in Saccharomyces cerevisiae. J. Gen. Microbiol 1987; 133: 1-8.
- Furuya E and Uyeda, K: Regulation of phosphofructokinase by a new mechanism. An activation factor binding to phosphorylated enzyme. J Biol Chem 1980; 255: 11656-59.
- Renu N, Yoshimune K, Wakayama M and Moriguchi M: Microbial glutaminase: biochemistry, molecular approaches and applications in the food industry. J Mol Catal 2003; 23: 87-100.
- Renu S and Chandrasekaran M: Extracellular L-Glutaminase production by marine bacteria. Biotechnol Lett 1992; 14: 471-74.
- Moriguchi M, Sakai K, Tateyama R, Furuta Y and Wakayama M: Isolation and characterization of salt-tolerant glutaminases from marine Micrococcus luteus K-3. J Ferment Bioeng 1994; 77: 621-25.
- Keerthi TR, Suresh PV, Sabu A, Rajeevkumar S and Chandrasekaran M: Extracellular production of L-Glutaminase by alkalophilic Beauveria bassiana BTMF S10 isolated from marine sediments. W J Microbiol Biotechnol 1999; 15: 751-52.
- Mates JM, Segura JA, Martin-Rufian M, Campos-Sandoval JA, Alonso and Marquez FJ: 514-34.
- Sato I, Kobayashi H, Hanya Y, Abe K, Murakami S, Scorzetti G and Fell JW: Cryptococcus nodaensis sp nov, a yeast isolated from soil in Japan that produces a salt-tolerant and thermostable glutaminase. J Indust Microbiol Biotechnol 1999; 22: 127-32.
- Kumar SR and Chandrasekaran M: Continuous production of L- glutaminase by an immobilized marine Pseudomonas BTMS-51 in a packed bed reactor. Proc Biochem 2003; 38: 1431-36.
- Ivakumar K, Sahu MK, Manivel PR and Kannan L: Optimum conditions for L-Glutaminase production by actinomycete strain isolated from estuarine fish, Chanos chanos (Forskal, 1775). Ind J Exp Biol 2006; 44: 256-58.
- Iyer PV and Singhal RS: Screening and Selection of Marine Isolate for L-Glutaminase Production and Media Optimization Using Response Surface Methodology. Appl Biochem Biotechnol 2009; 159: 233-50.
- ElSayed ASA: L glutaminase production by Trichoderma koningii under solid state fermentation. Ind J Microbiol 2009; 49: 243-50.
- Roberts J, Holcenberg JS and Dolowy WC: Isolation, crystallization and properties of Achromobacteraceae glutaminase– asparaginase with antitumor activity. J Biol Chem 1972; 247: 84-90.
- Dutt PLNSNS, Siddalingeshwara KG, Karthic J, Pramod T and Vishwanath T: Antitumour property L-glutaminase on from Aspergillus oryzae through submergrd fermentation. Int J Curr Microbiol App Sci 2014; 3(3): 819-23.
- Wakayama M, Yamagata T, Kamemura A, Bootim N, Yano S, Tachiki T, Yoshimune K and Moriguchi M: Characterization of salt-tolerant glutaminase from Stenotrophomonas maltophilia NYW-81 and its application in Japanese soy sauce fermentation. J. Ind. Microbiol. Biotechnol 2005; 32: 383-90.
- Hovarth RS: Bacterial Rev 1972; 36: 146.
- Ashraf SA and El-Sayed: Ind J Microbiol 2008; 1: 8.
- Iyer P and Singhal RS: Production of glutaminase (E.C.184.108.40.206) from Zygosaccharomyces rouxii: Statistical optimization using response surface methodology. Bioresour. Technol 2008; 99: 4300-30.
- Iyer P and Singhal RS: Glutaminase production using Zygosaccharomyces rouxii NRRL-Y 2547: Effect of aeration, agitation regimes and feeding strategies. Chem Eng Technol 2010, 33: 52-62.
- Kumar KP, Prabhakar T, Satish T, Sankar GG, Moges F, Lakhmi GS and Ramana H: J Pharmacy Chemistry 2009; 3(1): 4-7.
- Anusri T, Jagarlamudi S, Bai BP and Rao CSVR: Studies on isolation, screening and molecular charaterisation of L-Glutaminase Producing marine isolates. Tullimilli anusri et al., IJSID 2014; 4(1): 33-44.
- Prasanna KL and Raju KJ: Production of L-Glutaminase by Aspergillus oryzae NCIM 1212 under solid state fermentation using agro – residues J Chem Bio Phy Sci Sec B 2012; 2(1): 261-69.
- Soda: Purification and properties of isoenzymes of glutaminase from Pseudomonas aeroginosa. Biochem Biophys Res Commu 1972; 46: 1278-84.
- Roberts J: Purification and properties of highly potent anti-tumour glutaminase asparaginase from pseudomonas J Biol Chem 1976; 247: 84-90.
- Davidson L: Purification and properties of L-Glutaminase-L-asparaginase from Pseudomonas acidovorans. J Bacteriol 1977; 129(3): 1379-86.
- Shikata H, Yasui T, Ishigami Y and Oomori K: Studies on the glutaminase of Shoyu Koji (part 2). J Jpn Soy Sauce Res Inst 1979; 5: 21-25.
- Elshafei AM, Hassan MM, Ali NH, Abouzeid MAE, Mahmoud DA and Elghonemy DH: Purification, Kinetic Properties and Antitumor Activity of L- Glutaminase from Penicillium brevicompactum NRC 829 British Microbiology Research Journal 2014; 41: 97-15.
- Ramadan MEA, Asmar FEl and Greenberg DM: Purification and properties of glutaminase and asparaginase from a Pseudomonad. I. Purification and physical chemical properties. Arch Biochem Biophys 1964; 108: 143-49.
- Kozolov: Photosensitized oxidation of asparagine-glutamine deamidase from Pseudomonas fluorescens .B ulletin of Experimental Biology and Medicine 1982; 94(3): 1209-11.
- Ali TH, Ali NH and Mohamed LA: Glutamine amidohydrolase from Penicillium politans NRC 510. Pol J Food Nutr Sci 2009; 59(3): 211-17.
- Koibuchi K, Nagasaki H, Yuasa A, Kataoka J and Kitamoto K: Molecular cloning and characterization of a gene encoding glutaminase from Aspergillus oryzae. Appl Microbiol Biotechnol 2000; 54: 59-68
- Iwasa T, Fujii M and Yokotsuka T: Glutaminase produced by Cryptococcus albidus Purification and some properties of the enzyme. Nippon Shoyu Kenkyusho Zasshi 1987; 13: 205-10.
- Shimizu Y, Ueyama A and Goto K: Purification and characterization of glutaminase from Bacillus subtilis GT strain. J Brew Soc Jpn 1991; 86: 441-46.
- Dura MA, Flores M and Toldra F: Purification and characterisation of a glutaminase from Debaryomyces J Food Microbiol 2002; 76: 117-26.
- Laemmli, UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-85.
- Hughes D and Williamson D: Some properties of the glutaminase of Clostridium welchii. Biochem J 1952; 51(1): 45-55.
- Hartman and Stochaj: Hartman S. Glutaminase (Escherichia coli). Meth Enzymol 1973; 17A(134): 941-45.
- Huerta-Saqero: Over expression and purification of Rhizobium elti glutaminase A by recombinant and conventional procedures. A comparative study of enzymatic properties, protein expression purification 2000; 21: 432-37.
- Tachiki T, Yamada T, Mizuno K, Ueda M, Shiode J and Fukami H: γ- Glutamyl transfer reactions by glutaminase from Pseudomonas nitroreducens IFO 12694 and their application for the syntheses of theanine and γ-glutamyl methylamide. Biosci Biotechnol Biochem 1998; 62: 1279-83.
- Gilbert JB, Price VE and Greenstein JP: J Biol Chem 1949; 180: 209-18.
- Klein M, Kaltwasser H and Jahns T: Isolation of a novel, phosphate- activated glutaminase from Bacillus pasteurii. FEMS Microbiol Lett 2002; 206: 63-67.
- Ali TH, Ali NH and Mohamed LA: Glutamine amidohydrolase from Penicillium politans NRC 510. Pol. J Food Nutr Sci 2009; 59(3): 211-17.
- Sathish T and Prakasham RS: Isolation and identification of L-glutaminase an antileukemic enzyme producing micro-organism from Godavari river bank soils in Adhra Pradesh. IRJP 2010; 1: 367-73.
- Weingand- Ziade A, Gerber- Decombaz C and Affolter M: Functional characterization of a salt and thermo tolerant glutaminase from Lactobacillus rhamnosus. Enzyme Microb Technol 2003, 3: 862-67.
- Ali TH: Extent and Mode of Degradation of RNA Monomers by Extracts of Penicillium politans NRC 510. Journal of Biological Sciences 2009.
- Durai S, Selvaraj B, Manikkam R and Ramasamy B: Production and optimization of L-Glutaminase from Vibrio Sp. M9 Isolated from mahabalipuram marine Sediments. World Journal of Pharmaceutical Research 2014; 3(2): 2117.
- Kashyap P, Sabu A, Pandey A, Szakacs G and Carlos R: Extra-cellular L-Glutaminase production by Zygosaccharomyces rouxii under solid-state fermentation. Process Biochem 2002; 38: 307-31.
- Han JA and Park SC: Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer line. J Cancer Res Clin Oncol 1999; 125: 85-95.
- Nathiya K, Soraj SS, Angayarkanni J and Palaniswamy M: Optimised production of L- glutaminase: A tumor inhibitor from Aspergillus flavus cultured on agro industrial residues. Afr J Biotechnol 2011; 10: 13887-94.
- Kumar SS, Muthuvelayudham R and Viruthagiri T: Production and optimization of L-Glutaminase (EC.220.127.116.11) by Serratia marcescens using wheat bran under statistical designs. Journal of Chemical, Biological and Physical Sciences An International Peer Review E-3 Journal of Sciences 2013; 3(4): 2601-12.
- Mao Y, Xi L and Zhao L: Production of a Novel Salt-tolerant L-Glutaminase from Bacillus amyloliquefaciens Using Agro-industrial Residues and its Application in Chinese Soy Sauce Fermentation. Biotechnology 2013; 12(1): 25-35.
- Keerthi: Extracellular production of L-Glutaminase by alkalophilic Beauveria bassiana BTMF S10 isolated from marine sediments. W J Microbiol Biotechnol 1999; 15: 751-52.
- Pramod T, Athira RN and Elizebeth T: Investigation on the production of l-glutaminase from pseudomonas stutzeri strain under solid state fermentation using various agro residues. Journal of Drug Delivery & Therapeutics 2014; 4(2): 81-85.
- Jambulingam K: Production of L-Glutaminase and its optimization from a novel marine isolate Vibrio azureus JK-79. 2013; 12(50): 6944-53.
- Jeong-Min J, Hae-In L and Jae-Seong S: Glutaminase activity of Lactobacillus reuteri KCTC3594 and expression of the activity in other Lactobacillus spp. by introduction of the glutaminase gene. African Journal of Microbiology Research 2009; 3(10): 605-09.
- Abdallah NA, Amer SK and Habeeb MK: Production, purification and characterization of L-glutaminase enzyme from Streptomyces avermitilis. African J Microbiol Res 2013; 7: 1184-90.
- Kiruthika J and Saraswathy N: Production of L-Glutaminase and its optimization from a novel marine isolate Vibrio azureus. JK-79. Afr J Biotechnol 2013; 23(50): 6944-53.
- Krishnakumar S, Rajan RA and Ravikumar S: Extracellular production of L-glutaminase by marine alkalophilic Streptomyces sp.-SBU1 isolated from Cape Comorin Coast. Ind J Geo-Marine Sci 2011; 40: 717-21.
- Abdallah NA, Amer SK and Habeeb MK: Screening of L-glutaminase produced by actinomycetes isolated from different soils in Egypt. International Journal of Chem Tech Research coden 2012; 4(4): 1451-60.
- Nathiya K, Nath SS, Angayarkanni J and Palaniswamy M: In-vitro cytotoxicity of L-Glutaminase against mcf-7 cell lines. Academic Sciences, Asian Journal of Pharmaceutical and Clinical Research 2012; 5(2).
- Rosenfeld H and Roberts J: Enhancement of Antitumor activity of glutamine antagonists 6-diazo-5-oxo-l-norleucine and acivicin in cell culture by glutaminase-asparaginase, the journal of cancer research. Cancer Res 1981; 41: 1324.
- Tanaka: Structures of amidohydrolases aminoacid sequence of a glutaminase-asparginase from Acientobacter glutaminasificans and preliminary crystallographic data for an asparginase from Erwinia crysanthemi. J Biol Chem 263(18): 8583-91.
- Santana CF, Pinto V, Moreira LC and Lacerda AL: Action of swine kidney L-.Glutaminase on Ehrlich carcinoma. Rev Inst Antibiot 1968; 8: 105-07.
- Bauer K, Bierling R and Kaufman W: Naturwissenschaflen 1971; 58: 526.
- Bauer D, Gupta D, Harotunian V, Meador-Woodruff JH and Mc Cullumsmith RE: Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia. Schizophr Res 2008; 104: 108-1.
- 96. Hersh EM: L-Glutaminase: Suppression of Lymphocyte Blastogenic Responses in-vitro Science 1971: 172(3984): 736-38.
- Schamid FA and Roberts J: Antineoplastic and toxic effects of Acinetobacter and Pseudomonas glutaminase asparagines. Cancer Chemotherapy Rep 1974; 58(6): 829-40.
- Spiers AS and Wade HE: Bacterial glutaminase in treatment of acute leukaemia. Br Med J 1: 1317-19.
- Warrell: Phase I evaluation of succinylated Acinetobacter glutaminase-asparaginase in adults. Cancer Research (Impact Factor: 8.65) 1981; 40(12): 4546-51.
- 100. Belgoudi J: Poly(Ethylene glycol)-bovine serum albumin hydrogel as a matrix for enzyme immobilization. In-vitro biochemical characterization. Journal of Bioactive and Compatible Polymers 1999; 14(1): 31-53.
- Giordano: L-Glutaminase and L-asparaginase by extracorporeal route in acute lymphoblastic leukemia therapy. The International Journal of Artificial Organs 1981; 4(5): 244-248
- Samid D, Ram Z, Hudgins WR, Shack S, Liu L, Walbridge S, Oldfield EH and Myers CE: Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria. Cancer Res 1994; 54: 891.
- 103. Samid D, Wells M, Greene ME, Shen W, Palmer CNA and Thibault A: Peroxisome Proliferator-activated Receptor γ as a Novel Target in Cancer Therapy: Binding and Activation by an Aromatic Fatty Acid with Clinical Antitumor Activity. Clin Cancer Res March 2000 6; 933.
- Neish AS: Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136: 65-80.
- Lobo: Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells. Biochem. J 2000; 348: 257-61.
- Kumar RN, Yoshimune K, Wakayama M and Moriguchi M: Microbial Glutaminase: biochemistry, molecular approaches and applications in the food industry. J Mol Cat b: Enzymatic 2003; 23: 87-100.
- Fukushima and Motai: Continuous conversion of glutamine to glutamate by immobilized glutaminase-producing yeast. Journal of Fermentation and Bioengineering 1990; 69(3): 189091.
- Loeliger J: J Nutr 2000; 130: 915.
- Hamada JS and Mashall WE: Enhancement of peptidoglutaminase deamidation of soy protein by heat treatment and/or proteolysis. J Food Sci 53: 1132-34.
- Chou CC and Hwan CH: Effect of ethanol on the hydrolysis of protein and lipid during the ageing of a Chinese fermented soya bean curd-sufu. J Sci Food Agric 1994; 66: 393-98.
- Lu D, Pavlakis SG, Frank Y, Bakshi S, Pahwa S, Gould RJ, Sison C, Hsu C, Lesser M, Hoberman M, Barnett T and Hyman RA: Proton MR Spectroscopy of the basal ganglia in healthy children and children with AIDS. Radiology 1996; 199: 423-28.
- Sugiyama S: Selection of micro-organisms for use in the fermentation of soy sauce. Food Microbiol 1984; 1: 339- 47.
- Yamamoto S and Hirooka H: Production of glutaminase by Aspergillus sojae. J Ferment Technol 1974; 52: 564-69.
- Nakadai T and Nasuno S: Use of glutaminase for soy sauce made by Koji or a preparation of proteases from Aspergillus oryzae. Journal of Fermentation and Bioengineering 1989; 67(3): 158-62.
- Chou: Effect of ethanol on the hydrolysis of protein and lipid during the aging of a Chinese fermented soya bean curd-sufu. J Sci Food Agric 1993; 66: 393-98.
- Hamada JS: Deamidation of food proteins to improve functionality. Crit Rev Food Sci Nutr 1994; 34: 283-92.
- Kikuchi M and Sakaguchi K: Some enzymatic properties and substrate specidicities of peptidoglutaminase-I and II. Agr Biol Chem 1973; 37: 1813-21.
- Ushijima S, Nakadai T and Uchida K: Improvement of enzymes productivities through mutation or haploidization of heterozygous diploids obtained by protoplast-fusion of Aspergillus sojae. Agric Biol Chem 1987; 51: 2781-86.
- Villarta: Determination of glutamine in serum using an amperometric enzyme electrode, Electroanalysis 1992; 4: 27-31.
- Botre: Determination of l-glutamate and l-glutamine in pharmaceutical formulations by amperometric l-glutamate oxidase based enzyme sensors. Journal of Pharmaceutical and Biomedical Analysis 1993; 11(8): 679-86.
- 121. Huang: A new method for the assay of glutaminase activity: Direct measurement of product formation by an ammonia electrode ☆Analytical Biochemistry 1974; 61(2): 464-70.
- Mulchandani A and Bassi AS: Determination of glutamine and glutamic acid in mammalian cell cultures using tetrathiafulvalene modified enzyme electrodes, Biosensor Bioelectron 1996; 11: 271-80.
- Meyerhoff: Novel non separation sandwich-type electrochemical enzyme immunoassay system for detecting marker proteins in undiluted blood. Clin Chem 41(9): 1378-84.
- Wang JB: Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 2010; 18: 207-19.
- Schugerl K, Brandes L, Dullau T, Holzhauer- Rieger K, Hotop S, Hubner U, Wu X and Zhou W: Fermentation monitoring and control by on-line flow injection and liquid chromatography. Anal Chim 1991; 249: 87-100.
- Matuszewski W, Rosario SA and Meyerhoff ME: Operation of ion-selective electrode detectors in the sub-Nernstianflinear response range: Application to flow-injection/enzymatic determination of L-glutamine in bioreactor media. Anal Chem 1991; 63: 1906-1909.
- Tachiki T, Yamada T, Mizuno K, Ueda M, Shiode J and Fukami H: γ- Glutamyl transfer reactions by glutaminase from Pseudomonas nitroreducens IFO 12694 and their application for the syntheses of theanine and γ-glutamyl methylamide. Biosci Biotechnol Biochem 1998; 62: 1279-83.
- Abelian: A continuous production method for theanine by immobilized Pseudomonas nitroreducens Journal of Fermentation and Bioengineering 1993; 76(3): 195-98.
How to cite this article:
Unissa R, Sudhakar M, Reddy ASK and Sravanthi KN: A review on biochemical and therapeutic aspects of glutaminase. Int J Pharm Sci & Res 2014; 5(11): 4617-34. doi: 10.13040/IJPSR.0975-8232.5(11).4617-34.
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
R. Unissa *, M. Sudhakar, A. S. K. Reddy and K. N. Sravanthi
Malla Reddy College of Pharmacy, Maisammaguda, Dhulpally, Secunderabad, Hyderabad. India.
17 April 2014
28 June 2014
10 July 2014
01 November 2014